Development of a Sexually Differentiated Behavior and Its Underlying CNS Arousal Functions

Current Topics in Developmental Biology

Volumn 79, Issue , 2007, Pages 37-59

  Kow, Lee Ming ^a,b   Florea, Cristina ^a,b   Schwanzel Fukuda, Marlene ^a,b   Devidze, Nino ^a,b   Kami Kia, Hosein ^a,b   Lee, Anna ^a,b   Zhou, Jin ^a,b   MacLaughlin, David ^a,b   Donahoe, Patricia ^a,b   Pfaff, Donald ^a,b  

^a ROCKEFELLER UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MULLERIAN INHIBITING SUBSTANCE RECEPTOR; MULLERIAN-INHIBITING SUBSTANCE RECEPTOR; RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL; CENTRAL NERVOUS SYSTEM; GENETICS; HISTOLOGY; LORDOSIS; METABOLISM; PHYSIOLOGY; REVIEW; SEX DIFFERENTIATION; SEXUAL BEHAVIOR;

ANIMALS; CENTRAL NERVOUS SYSTEM; LORDOSIS; RECEPTORS, PEPTIDE; SEX DIFFERENTIATION; SEXUAL BEHAVIOR, ANIMAL;

EID: 34247887602     PISSN: 00702153     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0070-2153(06)79002-0     Document Type: Review

References (72)

1. Arnold A.P. Genetically triggered sexual differentiation of brain and behavior. Horm. Behav. 30 (1996) 495-505
2. Arnold A.P. Experimental analysis of sexual differentiation of the zebra finch brain. Brain Res. Bull. 44 (1997) 503-507
3. Arnold A.P., and Burgoyne P.S. Are XX and XY brain cells intrinsically different?. Trends Endocrinol. Metab. 15 (2004) 6-11
4. Baarends W.M., Van Helmond M.J.L., Post M., Hoogerbrugge J.W., Meijers J.H., Themmen A.P.N., and Grootegoed J.A. A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the mullerian duct. Development 120 (1994) 189-197
5. Baarends W.M., Hoogerbrugge J.W., Post M., Visser J.A., De Rooij D.G., Parvinen M., Themmen A.P., and Grootegoed J.A. Anti-mullerian hormone and anti-mullerian hormone type II receptor messenger ribonucleic acid expression during postnatal testis development and in the adult testis of the rat. Endocrinology 136 (1995) 5614-5622
6. Baarends W.M., Uilenbroek J.T., Kramer P., Hoogerbrugge J.W., van Leeuwen E.C., Themmen A.P., and Grootegoed J.A. Anti-mullerian hormone and anti-mullerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology 136 (1995) 4951-4962
7. Baker M.L., Metcalfe S.A., and Hutson J.M. Serum levels of mullerian inhibiting substance in boys from birth to 18 years, as determined by enzyme immunoassay. J. Clin. Endocrinol. Metab. 70 (1990) 11-15
8. Bauer H.-C., and Bauer H. Neural induction of the blood-brain barrier: Still an enigma. Cell. Mol. Neurobiol. 20 (2000) 13-28
9. Beach F.A. "Hormones and Behavior." (1948), Hoeber, New York
10. Becker J.B., Breedlove S.M., and Crews D. "Behavioral Endocrinology." (1992), MIT Press, Cambridge
11. Bezard J., Vigier B., Tran D., Mauleon P., and Josso N. Immunocytochemical study of anti-Mullerian hormone in sheep ovarian follicles during fetal and post-natal development. J. Reprod. Fertil. 80 (1987) 509-516
12. Breedlove S.M., Cooke B.M., and Jordan C.L. The orthodox view of brain sexual differentiation. Brain Behav. Evol. 54 (1999) 8-14
13. Cate R.L., Mattaliano R.L., Hession C., Tizard R., Farber N.M., Cheung A., Ninfa E.G., Frey A.Z., Gash D.J., Chow E.P., Fisher R.A., Bertonis J.M., et al. Isolation of the bovine and human genes for mullerian inhibiting substance and expression of the human gene in animal cells. Cell 45 (1986) 685-698
14. Catlin A., Manganaro T.F., and Donahoe P.K. Mullerian inhibiting substance depresses accumulation in vitro of disaturated phosphatidylcholine in fetal rat lung. Am. J. Obstet. Gynecol. 159 (1988) 1299-1303
15. Catlin E.A., Powell S.M., Manganaro T.F., Hudson P.L., Ragin R.C., Epstein J., and Donahoe P.K. Sex-specific fetal lung development and mullerian inhibiting substance. Am. Rev. Respir. Dis. 141 (1990) 466-470
16. Catlin E.A., Tonnu V.C., Ebb R.G., Pacheco B.A., Manganaro T.F., Ezzell R.M., Donahoe P.K., and Teixeira J. Mullerian inhibiting substance inhibits branching morphogenesis and induces apoptosis in fetal rat lung. Endocrinology 138 (1997) 790-796
17. Chin T., Parry R.L., and Donahoe P.K. Human mullerian inhibiting substance inhibits tumor growth in vitro and in vivo. Cancer Res. 51 (1991) 2101-2106
18. Clarke T.R., Hoshiya Y., Yi S.E., Liu X., Lyons K.M., and Donahoe P.K. Mullerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression. Mol. Endocrinol. 15 (2001) 946-959
19. Devidze N., Mong J., Jasnow A., Kow L.-M., and Pfaff D.W. Sex and estrogenic effects on coexpression of mRNAs in single ventromedial hypothalamic neurons. Proc. Natl. Acad. Sci. USA 102 (2005) 14446-14451
20. di Clemente N., Wilson C., Faure E., Boussin L., Tizard R., Picard J.-Y., Vigier B., and Cate R. Cloning, expression, and alternative splicing of the receptor for anti-Mullerian hormone. Mol. Endocrinol. 8 (1994) 1006-1020
21. Easton A., Jasnow A., Norton J., Goodwillie A., and Pfaff D.W. Sex differences in mouse behavior following pyrilamine treatment: Role of histamine 1 receptors in arousal. Pharmacol. Biochem. Behav. 7 (2004) 563-572
22. Floody O.R., and Arnold A.P. Song lateralization in the zebra finch. Horm. Behav. 31 (1997) 25-34
23. Garey J., Goodwillie A., Frohlich J., Morgan M., Gustafsson J.-A., Smithies O., Korach K., Ogawa S., and Pfaff D. Genetic contributions to generalized arousal of brain and behavior. Proc. Natl. Acad. Sci. USA 100 19 (2003) 11019-11022
24. Giedd J.N., Castellanos F.X., Rajapakse J.C., Vaituzis A.C., and Rapaport J.L. Sexual dimorphism of the developing human brain. Prog. Neuropsychopharmacol. Biol. Psychiatry 21 (1997) 1185-1201
25. Gorski R.A. Sexual dimorphisms of the brain. J. Anim. Sci. 3 Suppl. 61 (1985) 38-61
26. Haqq C.M., King C.Y., Ukiyama E., Falsafi S., Haqq T.N., Donahoe P.K., and Weiss M.A. Molecular basis of mammalian sexual determination: Activation of mullerian inhibiting substance gene expression by SRY. Science 266 (1994) 1494-1500 (Review)
27. Hudson P.L., Dougas I., Donahoe P.K., Cate R.L., Epstein J., Pepinsky R.B., and MacLaughlin D.T. An immunoassay to detect human mullerian inhibiting substance in males and females during normal development. J. Clin. Endocrinol. Metab. 70 (1990) 16-22
28. Hunter R.H. Aetiology of intersexuality in female (XX) pigs, with novel molecular interpretations. Mol. Reprod. Dev. 45 (1996) 392-402 (Review)
29. Ingraham H.A., Hirokawa Y., Roberts L.M., Mellon S.H., McGee E., Nachtigal M.W., and Visser J.A. Autocrine and paracrine Mullerian inhibiting substance hormone signaling in reproduction. Recent Prog. Horm. Res. 55 (2000) 53-67 (Review)
30. Josso N., Legeai L., Forest M.G., Chaussain J.L., and Brauner R. An enzyme linked immunoassay for anti-mullerian hormone: A new tool for the evaluation of testicular function in infants and children. J. Clin. Endocrinol. Metab. 70 (1990) 23-27
31. Josso N., di Clemente N., and Gouedard L. Anti-Mullerian hormone and its receptors. Mol. Cell. Endocrinol. 179 (2001) 25-32
32. Jost A. Problems of fetal endocrinology: The gonadal and hyophyseal hormones. Recent Prog. Horm. Res. 8 (1953) 379-418
33. Knobil E., and Neill J. "The Physiology of Reproduction,". 2nd ed. (1994), Raven, New York
34. Kolbinger W., Trepel M., Beyer C., and Reisert I. The influence of genetic sex on sexual differentiation of diencephalic dopaminergic neurons in vitro and in vivo. Brain Res. 544 (1991) 349-352
35. Kow L.-M., Mobbs C.V., and Pfaff D.W. Roles of second-messenger systems and neuronal activity in the regulation of lordosis by neurotransmitters, neuropeptides and estrogen: A review. Neurosci. Biobehav. Rev. 18 (1994) 251-268
36. Kow L.-M., Bogun M., and Pfaff D.W. Induction of lordosis and ear wiggling in rat pups with estrogen and progesterone: Age and gender differences. Society for Neuroscience (2005) (No. 321.15)
37. Kow L.-M., Easton A., and Pfaff D.W. Acute estrogen potentiates excitatory responses of neurons in rat hypothalamic ventromedial nucleus. Brain Res. 1043 1-2 (2005) 124-131
38. Kuroda T., Lee M.M., Haqq C.M., Powell D.M., Manganaro T.F., and Donahoe P.K. Müllerian inhibiting substance ontogeny and its modulation by follicle-stimulating hormone in the rate testes. Endocrinology 127 (1991) 1825-1832
39. Lee M.M., and Donahoe P.K. Mullerian inhibiting substance: A gonadal hormone with multiple functions. Endocr. Rev. 14 (1993) 152-164
40. Lee M.M., Seah C.C., Masiakos P.T., Sottas C.M., Preffer F.I., Donahoe P.K., MacLaughlin D.T., and Hardy M.P. Mullerian-inhibiting substance type II receptor expression and function in purified rat Leydig cells. Endocrinology 140 (1999) 2819-2827
41. Masiakos P.T., MacLaughlin D.T., Maheswaran S., Teixeira J., Fuller Jr. A.F., Shah P.C., Kehas D.J., Kenneally M.K., Dombkowski D.M., Ha T.U., Preffer F.I., and Donahoe P.K. Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS. Clin. Cancer Res. 5 (1999) 3488-3499
42. Massague J. TGF-beta signal transduction. Annu. Rev. Biochem. 67 (1998) 753-791
43. Maxson S.C. Searching for candidate genes with effects on an agonistic behavior, offense, in mice. Behav. Genet. 26 (1996) 471-476
44. McClintock M., and Newman S. In: Pfaff D., et al. (Ed). "Hormones, Brain and Behaviors" (2002), Academic Press, San Diego
45. Morrell J.I., and Pfaff D.W. A neuroendocrine approach to brain function: Localization of sex steroid concentrating cells in vertebrate brains. Am. Zool. 18 (1978) 447-460
46. Pfaff D.W. Autoradiographic localization of radioactivity in rat brain after injection of tritiated sex hormones. Science 161 (1968) 1355-1356
47. Pfaff D.W. Luteinizing hormone releasing factor potentiates lordosis behavior in hypophysectomized ovariectomized female rats. Science 182 (1973) 1148-1149
48. Pfaff D.W. "Estrogens and Brain Function: Neural Mechanisms for a Hormone-Dependent Behavior." (1980), Springer-Verlag, New York
49. Pfaff D.W. "Drive: Neurobiological and Molecular Mechanisms of Sexual Motivation." (1999), MIT Press, Cambridge
50. Pfaff D.W. "Brain Arousal and Information Theory: Neural and Genetic Mechanisms." (2006), Harvard University Press, Cambridge
51. Pfaff D.W., and Keiner M. Atlas of estradiol-concentrating cells in the central nervous system of the female rat. J. Comp. Neurol. 151 (1973) 121-158
52. Pfaff D.W., and Zigmond R.E. Neonatal androgen effects on sexual and nonsexual behavior of adult rats tested under various hormone regimes. Neuroendocrinology 7 (1971) 129-145
53. In: Pfaff D.W., Arnold A., Etgen A., Fahrbach S.E., and Rubin R.T. (Eds). "Hormones, Brain and Behavior," 5 vols (2002), Academic Press, San Diego
54. Pfaff D.W., Westberg L., and Kow L.-M. Generalized arousal of mammalian central nervous systems. J. Comp. Neurol. 493 (2005) 86-91
55. Phoenix C.H., Goy R., Gerall A., and Young W.C. Organizing action of prenatally administered testosterone on the tissues mediating maternal behavior in the female guinea pig. Endocrinology 65 (1959) 369-382
56. Racine C., Rey R., Forest M.G., Louis F., Ferre A., Huhtaniemi I., Josso N., and di Clemente N. Receptors for anti-mullerian hormone on Leydig cells are responsible for its effects on steroidogenesis and cell differentiation. Proc. Natl. Acad. Sci. USA 95 (1998) 594-599
57. Rajpert-De Meyts E., Jorgensen N., Graem N., Muller J., Cate R.L., and Skakkebaek N.E. Expression of anti-Mullerian hormone during normal and pathological gonadal development: Association with differentiation of Sertoli and granulosa cells. J. Clin. Endocrinol. Metab. 84 (1999) 3836-3844
58. Risau W., Hallmann R., and Albrecht U. Differentiation-dependent expression of proteins in brain endothelium during development of the blood-brain barrier. Dev. Biol. 117 (1986) 537-545
59. Schwanzel-Fukuda M., and Pfaff D.W. Origin of luteinizing hormone-releasing hormone neurons. Nature 338 (1989) 161-164
60. Schwanzel-Fukuda M., Bick D., and Pfaff D.W. Luteinizing hormone-releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome. Mol. Brain Res. 6 (1989) 311-326
61. Segev D.L., Ha T.U., Tran T.T., Kenneally M., Harkin P., Jung M., MacLaughlin D.T., Donahoe P.K., and Maheswaran S. Mullerian inhibiting substance inhibits breast cancer cell growth through an NFkappa B-mediated pathway. J. Biol. Chem. 275 (2000) 28371-28379
62. Shughrue P.J., Lane M.V., and Merchenthaler I. Comparative distribution of estrogen receptor alpha and beta mRNA I the rat central nervous system. J. Comp. Neurol. 388 (1997) 507-525
63. Simerly R.B. Organization and regulation of sexually dimorphic neuroendocrine pathways. Behav. Brain Res. 92 (1998) 195-203
64. Stephen A.E., Masiakos P.T., Segev D.L., Vacanti J.P., Donahoe P.K., and MacLaughlin D.T. Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivo. Proc. Natl. Acad. Sci. USA 98 (2001) 3214-3219
65. Stephen A.E., Pearsall L.A., Christian B.P., Donahoe P.K., Vacanti J.P., and MacLaughlin D.T. Highly purified Mullerian Inhibiting Substance inhibits ovarian cancer in vivo. Clin. Cancer Res. 8 (2002) 2640-2646
66. Takahashi M., Hayashi M., Manganaro T.F., and Donahoe P.K. The ontogeny of mullerian inhibiting substance in granulosa cells of the bovine ovarian follicle. Biol. Reprod. 35 (1986) 447-453
67. Teixeira J., and Donahoe P.K. Molecular biology of MIS and its receptors. J. Androl. 17 (1996) 336-341
68. Teixeira J., He W.W., Shah P.C., Morikawa N., Lee M.M., Catlin E.A., Hudson P.L., Wing J., MacLaughlin D.T., and Donahoe P.K. Developmental expression of a candidate mullerian inhibiting substance type II receptor. Endocrinology 137 (1996) 160-165
69. Teixeira J., Kehas D.J., Antun R., and Donahoe P.K. Transcriptional regulation of the rat mullerian inhibiting substance type II receptor in rodent Leydig cells. Proc. Natl. Acad. Sci. USA 96 (1999) 13831-13838
70. Teng C.S. Quantification of mullerian inhibiting substance in developing chick gonads by a competitive enzyme-linked immunosorbent assay. Dev. Biol. 123 (1987) 255-263
71. Visser J.A., Olaso R., Verhoef-Post M., Kramer P., Themmen A.P., and Ingraham H.A. The serine/threonine transmembrane receptor ALK2 mediates Mullerian inhibiting substance signaling. Mol. Endocrinol. 15 (2001) 936-945
72. Wu T.J., Glucksman M.J., Roberts J.L., and Mani S.K. Facilitation of lordosis in rats by a metabolite of luteinizing hormone releasing hormone. Endocrinology 147 (2006) 2544-2549